| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/27/2001 | US20010024817 Viral nucleotide sequences |
| 09/27/2001 | US20010024815 Production of thermostable xyalnases useful for modifying plant biomass and for enzyme-aided bleaching of wood pulp |
| 09/27/2001 | US20010024814 Recognizes a specific sugar chain structure in a saccharide and introduces a n-acetylglucosamine beta 1-4 branching structure |
| 09/27/2001 | US20010024813 Human dendriac and brainiac-3 |
| 09/27/2001 | US20010024812 Methods and compositions for producing full length cDNA libraries |
| 09/27/2001 | US20010024811 A polyketide synthase comprised of modules, and that has been modified to prevent its utilization of the native starter unit |
| 09/27/2001 | US20010024810 Libraries of polyketides synthesized by a multiplicity of polyketide synthases that are derived from naturally occuring synthases that contain regions that encode enzymatic activities and scaffolding amino acid sequences |
| 09/27/2001 | US20010024807 Polynucleotides encoding crippled selectable marker such as neomycin resistance; heterologous polypeptides of interest; amplifiable selectable marker such as dehydrofolate reductase |
| 09/27/2001 | US20010024794 Expression of reporter gene that encodes a fluorescent polypeptide used to detect interaction between bait and prey protein; nondestructive |
| 09/27/2001 | US20010024793 Nucleic acid-free thermostable enzymes and methods of production thereof |
| 09/27/2001 | US20010024790 DNA base sequencing system |
| 09/27/2001 | US20010024789 Identifying nucleic acid molecules which encode enzymes using nucleic acid-protein fusions |
| 09/27/2001 | US20010024787 Compositions, kits, and methods for hydrodynamic stress-related regulation of gene expression |
| 09/27/2001 | US20010024786 Purified polypeptide of given sequence; useful in diagnosis, prevention, and treatment of cancer, inflammation, and disorders of fatty acid metabolism |
| 09/27/2001 | US20010024784 Binding reagents comprising nucleic acid-protein fusions, each having a protein portion that specifically binds to one of the compounds to be detected, and a nucleic acid which encodes the protein portio and a uniquie identification tag |
| 09/27/2001 | US20010024783 By administering a heat and RnaseH resistant antisense agent and detecting the presence in a body fluid sample of a nuclease-resistant heteroduplex of the antisense oligomer and the target RNA; detecting infective agents, pregnancy |
| 09/27/2001 | US20010024782 Procaryotic cells containing a diverse population of expressible oligonucleotides operationally linked to expression elements, the oligonucleotides having a desirable bias of random codon sequences; kits |
| 09/27/2001 | US20010024653 Recombinant mycobacterium strain containing in its chromosome or on a plasmid a counterpart to a gene (which has been deactivated) in the wild type mycobacterium coding for a protein necessary for biosynthesis of a purine or pyrimidine |
| 09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
| 09/27/2001 | US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection |
| 09/27/2001 | US20010024647 Single chain variable region immunoglobulin (ScFv) fragment antibody that binds selectively to the active conformation of human von Willebrand Factor (vWF) and the antibody inhibits the binding of vWF to platelets |
| 09/27/2001 | DE10015413A1 Composition for treating and diagnosing viral infections, caused by adenovirus, comprises an agent that modifies function of YB-1 protein, and YB-1 specific antibodies |
| 09/27/2001 | DE10014546A1 Für das dapC-Gen kodierende Nukleotidsequenzen und Verfahren zur Herstellung von L-Lysin DapC gene coding for the nucleotide sequences and methods for producing L-lysine |
| 09/27/2001 | DE10014085A1 Cytochrome P450 monooxygenase for oxidizing organic compounds, useful especially for converting indole to indigo, has wide substrate range |
| 09/27/2001 | DE10013995A1 Magnetic polyvinyl alcohol carrier material in particle, filter or membrane form for use in isolation of e.g. DNA or in automatic diagnoses is at least partly surface silanized |
| 09/27/2001 | DE10013732A1 New DNA sequence encoding potassium channel KCNQ5, useful in screening for specific modulators, potential agents for treating central nervous system and cardiovascular diseases |
| 09/27/2001 | DE10011530A1 New antisense oligonucleotides that inhibit polo-like kinase, useful for treating tumors that overexpress this kinase, have strong and selective action |
| 09/27/2001 | DE10011022A1 Apparatus for performing synthesis, analysis or transport processes with a process fluid has a reaction zone with controlled delivery of a process fluid and control fluids with inner analysis and reaction interfaces at the side walls |
| 09/27/2001 | CA2689798A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | CA2684455A1 Method and apparatus for processing substances in a single container |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404825A1 Precursors of silk-like materials, silk-like materials and processes for producing both |
| 09/27/2001 | CA2404260A1 Identification of essential genes in prokaryotes |
| 09/27/2001 | CA2404253A1 Novel ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | CA2404216A1 Novel polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | CA2404139A1 Binding compounds and methods for identifying binding compounds |
| 09/27/2001 | CA2404088A1 Bi-functional cancer treatment agents |
| 09/27/2001 | CA2404009A1 Magnetic, silanised polyvinylalcohol-based carrier materials |
| 09/27/2001 | CA2403815A1 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | CA2403809A1 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | CA2403804A1 Vegf-modulated genes and methods employing them |
| 09/27/2001 | CA2403795A1 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | CA2403788A1 Receptor-binding compounds and methods for identifying them |
| 09/27/2001 | CA2403784A1 Binding compounds and methods for identifying binding compounds |
| 09/27/2001 | CA2403708A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 09/27/2001 | CA2403684A1 Therapeutic anti-melanoma compounds |
| 09/27/2001 | CA2403681A1 Therapeutic anti-cytomegalovirus compounds |
| 09/27/2001 | CA2403636A1 Human secreted proteins and polynucleotides encoding the same |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403567A1 Methods and compositions for elucidating protein expression profiles in cells |
| 09/27/2001 | CA2403486A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | CA2403444A1 Restenosis treatment |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2403259A1 Method for determination of gene function |
| 09/27/2001 | CA2403162A1 Genetic silencing |
| 09/27/2001 | CA2403090A1 Whole-body optical imaging of gene expression and uses thereof |
| 09/27/2001 | CA2402924A1 Method of generating transgenic organisms using transposons |
| 09/27/2001 | CA2402834A1 Brca-1 regulators and methods of use |
| 09/27/2001 | CA2402816A1 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402757A1 Helical protein zalpha51 |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402722A1 Sperm factor oscillogenin |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2402463A1 Transformed plant having heterologous glucan branching enzyme activity |
| 09/27/2001 | CA2402380A1 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | CA2402285A1 Nimr compositions and their methods of use |
| 09/27/2001 | CA2402271A1 Combined polynucleotide sequences as discrete assay endpoints |
| 09/27/2001 | CA2402266A1 Methods for transforming plant plastids and making transplastomic plants |
| 09/27/2001 | CA2402263A1 Polymer coated surfaces for microarray applications |
| 09/27/2001 | CA2402252A1 Salmonella vaccine materials and methods |
| 09/27/2001 | CA2401991A1 Melon promoters for expression of transgenes in plants |
| 09/27/2001 | CA2401987A1 Receptors for hypersensitive response elicitors and uses thereof |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2399028A1 Use of mia in immunotherapy |
| 09/27/2001 | CA2383848A1 Diagnosis of a person's risk of developing alcoholism |
| 09/27/2001 | CA2374406A1 Microarray-based analysis of polynucleotide sequence variations |
| 09/27/2001 | CA2374393A1 Methods of detecting polynucleotide kinase and its use as a label |
| 09/27/2001 | CA2374265A1 Process for the fermentative preparation of l-amino acids with amplification of the gnd gene |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136933A2 Systems and computer software products for gene expression analysis |
| 09/26/2001 | EP1136571A2 Detection of polymorphisms in the MxA gene to predict the response of an hepatitis C virus infected individual to interferon therapy |
| 09/26/2001 | EP1136570A2 Carrier for gene detection and it's use for detecting validity of interferon therapy |
| 09/26/2001 | EP1136567A1 Method and kit for the screening, the detection and /or the quantification of transcriptional factors |
| 09/26/2001 | EP1136565A1 Method for characterizing membrane-associated polypeptides |
| 09/26/2001 | EP1136562A2 Feline leukemia virus vaccines |
| 09/26/2001 | EP1136561A2 Targeting gene therapy |
| 09/26/2001 | EP1136560A1 Vectors for transforming plants |
| 09/26/2001 | EP1136559A2 Nucleotide sequences coding for the dapC-gene and process for the preparation of L-lysine |
| 09/26/2001 | EP1136558A1 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/26/2001 | EP1136557A1 Proteins and polypeptides from Haemophilus influenzae involved in paracytosis, nucleotide sequences encoding them and uses thereof |
| 09/26/2001 | EP1136556A1 Multivalent antigen-binding proteins |
| 09/26/2001 | EP1136555A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof |
| 09/26/2001 | EP1136554A1 ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| 09/26/2001 | EP1136553A1 Production of recombinant blood clotting factors in human cell lines |
| 09/26/2001 | EP1136552A1 ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| 09/26/2001 | EP1136551A1 Direct isolation of transposon insertions tagging transcribed portions of genes |
| 09/26/2001 | EP1136549A1 Dnas encoding novel polypeptides |